angiotensin ii has been researched along with goralatide in 21 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (9.52) | 18.2507 |
2000's | 7 (33.33) | 29.6817 |
2010's | 10 (47.62) | 24.3611 |
2020's | 2 (9.52) | 2.80 |
Authors | Studies |
---|---|
Azizi, M; Boulanger, CM; Ezan, E; Lévy, BI; Massé, F; Mathieu, E | 1 |
Ezan, E; Fraser, C; Junot, C; MacFadyen, R; Morton, JJ; Robson, J; Struthers, AD | 1 |
Carretero, OA; Harding, P; LaPointe, MC; Peng, H; Rhaleb, NE; Tayeh, M | 1 |
Beau, F; Cotton, J; Czarny, B; Dive, V; Georgiadis, D; Yiotakis, A | 1 |
Graham, RM; Husain, A; Li, M | 1 |
Bohnemeier, H; Cleutjens, JP; Crijns, HJ; Paul, M; Pinto, YM; Pokharel, S; Schunkert, H; Sharma, UC; Tian, XL; van Geel, PP | 1 |
Carretero, OA; Cavasin, MA; Liao, TD; Yang, JJ; Yang, XP | 1 |
Carretero, OA; Harding, P; Peng, H; Pokharel, S; Rasoul, S; Rhaleb, NE; Sharma, U | 1 |
Carretero, OA; D'Ambrosio, MA; Liao, TD; Lin, CX; Rhaleb, NE; Yang, XP | 1 |
Mou, YL; Xie, YY; Zhang, YC | 1 |
Brann, D; Cheng, H; Cheng, T; Li, S; Sun, Y; Wang, R; Wei, Z; Xu, H; Yang, F; Yuan, Y | 1 |
Kong, XQ; Wang, T; Wang, WH | 1 |
Carretero, OA; Dai, X; González, GE; Leung, P; Liao, TD; Liu, Y; Nakagawa, P; Rhaleb, NE; Yang, XP | 1 |
Deng, H; Du, S; Li, S; Sun, Y; Tian, J; Wei, Z; Xu, D; Xu, H; Xue, X; Yang, F; Yang, Y | 1 |
Fujioka, K; Fujioka, T; Itoh, H; Katagiri, F; Mimata, H; Sato, F; Sato, Y; Suzuki, Y | 1 |
Brann, D; Geng, YC; Li, SF; Liu, Y; Peng, HB; Xu, H; Yang, F; Yang, XH; Zhang, Y; Zhu, LY | 1 |
Bernstein, EA; Bernstein, KE; Cao, DY; Eriguchi, M; Fuchs, S; Giani, JF; Gonzalez-Villalobos, RA; Khan, Z; McDonough, AA; Toblli, JE; Veiras, LC | 1 |
Gao, X; Li, S; Wang, R; Wei, Z; Xu, D; Xu, H; Yang, F; Yi, X; Zhang, B; Zhang, G; Zhang, H; Zhang, L; Zhang, X; Zhang, Y; Zhu, Y | 1 |
Cai, W; Gao, X; Hao, X; Jin, F; Li, D; Li, S; Liu, H; Liu, Y; Mao, N; Tao, T; Wei, Z; Xu, D; Xu, H; Yang, F; Zhang, B; Zhang, G; Zhang, H; Zhang, L | 1 |
Gao, X; Ge, X; Jin, F; Li, S; Li, Y; Mao, N; Wei, Z; Xu, H; Yang, F; Yang, Y; Zhang, M; Zhang, Y | 1 |
Bernstein, EA; Bernstein, KE; Cao, D; Giani, JF; Gonzalez-Villalobos, RA; Khan, Z; Okwan-Duodu, D; Shen, JZY; Veiras, LC | 1 |
2 review(s) available for angiotensin ii and goralatide
Article | Year |
---|---|
[Research progress in relations between renin angiotensin system and diabetic cardiomyopathy].
Topics: Angiotensin I; Angiotensin II; Animals; Apoptosis; Diabetic Cardiomyopathies; Humans; NF-kappa B; Oligopeptides; Peptide Fragments; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Signal Transduction; Transforming Growth Factor beta1 | 2011 |
Novel roles of the renal angiotensin-converting enzyme.
Topics: Acute Kidney Injury; Angiotensin I; Angiotensin II; Animals; Blood Pressure; Bradykinin; Diabetic Nephropathies; Gene Expression Regulation; Humans; Hypertension; Kidney; Mice; Oligopeptides; Peptide Fragments; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Signal Transduction; Water-Electrolyte Balance | 2021 |
1 trial(s) available for angiotensin ii and goralatide
Article | Year |
---|---|
Nonadherence with angiotensin-converting enzyme inhibitor therapy: a comparison of different ways of measuring it in patients with chronic heart failure.
Topics: Aged; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Chronic Disease; Diuretics; Drug Therapy, Combination; Echocardiography; Furosemide; Heart Failure; Humans; Lisinopril; Oligopeptides; Peptidyl-Dipeptidase A; Radionuclide Ventriculography; Treatment Outcome; Treatment Refusal | 1999 |
18 other study(ies) available for angiotensin ii and goralatide
Article | Year |
---|---|
The hemoregulatory peptide N-acetyl-ser-asp-lys-pro impairs angiotensin I-induced contractions in rat aorta.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Drug Interactions; In Vitro Techniques; Male; Oligopeptides; Rats; Rats, Wistar; Vasoconstriction | 1998 |
Effect of N-acetyl-seryl-aspartyl-lysyl-proline on DNA and collagen synthesis in rat cardiac fibroblasts.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Cell Division; Cells, Cultured; Collagen; DNA; Dose-Response Relationship, Drug; Endothelin-1; Enzyme Activation; Enzyme Inhibitors; Fibrosis; Gene Expression Regulation; Humans; Hypertension; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Myocardium; Oligopeptides; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Renin-Angiotensin System | 2001 |
Roles of the two active sites of somatic angiotensin-converting enzyme in the cleavage of angiotensin I and bradykinin: insights from selective inhibitors.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Binding Sites; Bradykinin; Dose-Response Relationship, Drug; Drug Stability; Humans; Male; Mice; Mice, Inbred C57BL; Oligopeptides; Peptidyl-Dipeptidase A; Phosphinic Acids; Substrate Specificity | 2003 |
Do studies with ACE N- and C-domain-selective inhibitors provide evidence for a non-ACE, non-chymase angiotensin II-forming pathway?
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Binding Sites; Bradykinin; Chymases; Humans; Molecular Mimicry; Oligopeptides; Peptidyl-Dipeptidase A; Protein Structure, Tertiary; Serine Endopeptidases; Substrate Specificity | 2003 |
Increased myocardial collagen content in transgenic rats overexpressing cardiac angiotensin-converting enzyme is related to enhanced breakdown of N-acetyl-Ser-Asp-Lys-Pro and increased phosphorylation of Smad2/3.
Topics: Activin Receptors, Type I; Angiotensin II; Animals; Animals, Genetically Modified; Binding, Competitive; Collagen; DNA-Binding Proteins; DNA, Complementary; Fibrosis; Humans; Hypertrophy, Left Ventricular; Myocardium; Oligopeptides; Peptidyl-Dipeptidase A; Phosphorylation; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Rats; Rats, Sprague-Dawley; Receptor, Transforming Growth Factor-beta Type I; Receptors, Transforming Growth Factor beta; Smad2 Protein; Smad3 Protein; Substrate Specificity; Trans-Activators; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2004 |
Decreased endogenous levels of Ac-SDKP promote organ fibrosis.
Topics: Angiotensin II; Animals; Arginine Vasopressin; Collagen; Fibrosis; Glomerular Mesangium; Glomerulosclerosis, Focal Segmental; Kidney; Male; Myocardium; Oligopeptides; Prolyl Oligopeptidases; Protease Inhibitors; Rats; Rats, Sprague-Dawley; Serine Endopeptidases; Substance P; Time Factors | 2007 |
Novel anti-inflammatory mechanisms of N-Acetyl-Ser-Asp-Lys-Pro in hypertension-induced target organ damage.
Topics: Angiotensin II; Animals; Anti-Inflammatory Agents; Azo Compounds; Blotting, Western; Cardiomegaly; Cell Separation; Collagen; Fibrosis; Galectin 3; Heart Rate; Hypertension; In Vitro Techniques; Inflammation; Kidney; Male; Mice; Mice, Inbred C57BL; Myocardium; Neutrophil Infiltration; Oligopeptides; Stem Cells; Tumor Necrosis Factor-alpha | 2008 |
Prevention of aortic fibrosis by N-acetyl-seryl-aspartyl-lysyl-proline in angiotensin II-induced hypertension.
Topics: Angiotensin II; Animals; Aorta; Collagen; Elastin; Enzyme Activation; Fibrosis; Heart Diseases; Hypertension; Immunohistochemistry; Intercellular Adhesion Molecule-1; Lipid Metabolism; Male; Neutrophil Infiltration; Oligopeptides; Oxidation-Reduction; Phosphorylation; Protein Kinase C; Rats; Rats, Sprague-Dawley; Smad2 Protein; Transforming Growth Factor beta1; Vasoconstrictor Agents | 2008 |
A new antifibrotic target of Ac-SDKP: inhibition of myofibroblast differentiation in rat lung with silicosis.
Topics: Actins; Angiotensin II; Animals; Cell Differentiation; Collagen Type I; Collagen Type III; Lung; Male; Myofibroblasts; Oligopeptides; Pyrazoles; Pyrroles; Rats; Rats, Wistar; Receptors, Transforming Growth Factor beta; RNA, Messenger; Silicosis; Transforming Growth Factor beta1 | 2012 |
[Effects of Ac-SDKP on angiotensin II-induced collagen synthesis in vascular adventitial fibroblasts].
Topics: Angiotensin II; Animals; Cells, Cultured; Collagen Type I; Collagen Type III; Fibroblasts; Flavonoids; Male; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Oligopeptides; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta1 | 2013 |
N-acetyl-seryl-aspartyl-lysyl-proline reduces cardiac collagen cross-linking and inflammation in angiotensin II-induced hypertensive rats.
Topics: Amino Acid Oxidoreductases; Angiotensin II; Animals; Body Weight; Cardiomegaly; CD4-Positive T-Lymphocytes; Collagen; Extracellular Matrix; Hypertension; Inflammation; Lung; Male; NF-kappa B; Oligopeptides; Organ Size; Protein-Lysine 6-Oxidase; Rats; Rats, Inbred Lew; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Ventricular Function, Left; Ventricular Remodeling | 2014 |
[Inhibition effect of N-acetyl-seryl-aspartyl-lysyl-proline on myofibroblast differentiation of MRC-5 human fetal lung fibroblasts inuced by Ang II].
Topics: Actins; Angiotensin II; Cell Differentiation; Collagen; Collagen Type I; Cyclic AMP; Fetus; Fibroblasts; Guanine Nucleotide Exchange Factors; Humans; Lung; Myofibroblasts; Oligopeptides; Serum Response Factor; Trans-Activators | 2014 |
Clinical Implications of Plasma N-acetyl-seryl-aspartyl-lysyl-proline Level in Stable Kidney Transplant Recipients.
Topics: Adolescent; Adult; Aged; Anemia; Angiotensin II; Biomarkers; Creatinine; Erythropoietin; Humans; Kidney Failure, Chronic; Kidney Transplantation; Middle Aged; Oligopeptides; Postoperative Complications; Prolyl Oligopeptidases; Serine Endopeptidases; Young Adult | 2016 |
Influence of the interaction between Ac‑SDKP and Ang II on the pathogenesis and development of silicotic fibrosis.
Topics: Angiotensin II; Animals; Biomarkers; Collagen Type I; Lung; Male; Matrix Metalloproteinase 1; Myofibroblasts; Oligopeptides; Peptidyl-Dipeptidase A; Protein Binding; Rats; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Silicosis; Tissue Inhibitor of Metalloproteinase-1 | 2018 |
The Absence of the ACE N-Domain Decreases Renal Inflammation and Facilitates Sodium Excretion during Diabetic Kidney Disease.
Topics: Amino Acid Substitution; Angiotensin II; Animals; Catalytic Domain; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Epithelial Sodium Channels; Inflammation; Interleukin-1beta; Kidney; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mutagenesis, Site-Directed; Natriuresis; Oligopeptides; Peptidyl-Dipeptidase A; Protein Domains; Renin-Angiotensin System | 2018 |
Targeting the RAS axis alleviates silicotic fibrosis and Ang II-induced myofibroblast differentiation via inhibition of the hedgehog signaling pathway.
Topics: Adult; Aged; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Anthracosis; Captopril; Cell Differentiation; Cell Line; Collagen; Disease Models, Animal; Female; Hedgehog Proteins; Humans; Lung; Male; Middle Aged; Myofibroblasts; Oligopeptides; Peptide Fragments; Pulmonary Fibrosis; Rats, Wistar; Renin-Angiotensin System; Signal Transduction; Silicosis | 2019 |
Interaction of N-acetyl-seryl-aspartyl-lysyl-proline with the angiotensin-converting enzyme 2-angiotensin-(1-7)-Mas axis attenuates pulmonary fibrosis in silicotic rats.
Topics: Actins; Angiotensin I; Angiotensin II; Animals; Cell Differentiation; Cells, Cultured; Collagen; Collagen Type I; Fibroblasts; Humans; Male; Oligopeptides; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Pulmonary Fibrosis; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Silicosis | 2019 |
N-Acetyl-Seryl-Asparyl-Lysyl-Proline regulates lung renin angiotensin system to inhibit epithelial-mesenchymal transition in silicotic mice.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cell Line; Epithelial-Mesenchymal Transition; Fibrosis; Losartan; Lung; Male; Mice, Inbred C57BL; Oligopeptides; Peptide Fragments; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Silicosis | 2020 |